CXCL12, CXCR4 and CXCR7 expression in brain metastases

Brain metastases occur in about 25% of patients who die of cancer. The most common sources of brain metastases in adults are lung, breast, kidney, colorectal cancer and melanoma. The chemokine/receptor system CXCL12/CXCR4 plays a key role in multiple biological functions; among these, homing of neoplastic cells from the primary site to the target and metastasis progression. Recently, an alternative CXCL12 receptor, CXCR7, has been discovered. The aim of our study was to investigate the expression of CXCL12 and its receptors CXCR4 and CXCR7 by immunohistochemistry in 56 patients with metastatic brain disease from different non-CNS primary tumors and evaluate their prognostic relevance as well as that of other patient/treatment-related features on patient survival. CXCL12 showed an expression in tumor cells and in tumor vessels; CXCR7 was expressed by tumor and endothelial cells (both within the tumor and in the adjacent brain tissue), while CXCR4 showed a positivity in all samples with a nuclear pattern. Among the investigated immunohistochemical parameters, only CXCL12 expression in tumor endothelial cells showed a statistically significant correlation with shorter survival (p=0.04 log-rank), perhaps identifying more aggressive tumors. Thus, this is the first study evaluating at the same time the expression of CXCL12 and its two receptors in a cohort of brain metastases.

[1]  Cimona V Hinton,et al.  Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain , 2010, Clinical & Experimental Metastasis.

[2]  S. Schulz,et al.  Reassessment of CXCR4 Chemokine Receptor Expression in Human Normal and Neoplastic Tissues Using the Novel Rabbit Monoclonal Antibody UMB-2 , 2008, PloS one.

[3]  E. Thiel,et al.  Nuclear expression of CXCR4 in tumor cells of non-small cell lung cancer is correlated with lymph node metastasis. , 2008, Human pathology.

[4]  M. Thelen,et al.  CXCR7, CXCR4 and CXCL12: An eccentric trio? , 2008, Journal of Neuroimmunology.

[5]  K. Pienta,et al.  The Role of CXCR7/RDC1 as a Chemokine Receptor for CXCL12/SDF-1 in Prostate Cancer* , 2008, Journal of Biological Chemistry.

[6]  Alnawaz Rehemtulla,et al.  CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature , 2007, Proceedings of the National Academy of Sciences.

[7]  Richard P. Harvey,et al.  Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7 , 2007, Proceedings of the National Academy of Sciences.

[8]  X. Bian,et al.  PREFERENTIAL EXPRESSION OF CHEMOKINE RECEPTOR CXCR4 BY HIGHLY MALIGNANT HUMAN GLIOMAS AND ITS ASSOCIATION WITH POOR PATIENT SURVIVAL , 2007, Neurosurgery.

[9]  S. Rafii,et al.  The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. , 2007, Trends in immunology.

[10]  Judong Pan,et al.  Stromal Derived Factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis , 2006, Molecular Cancer.

[11]  B. Gao,et al.  Regulation of the chemokine receptor CXCR4 and metastasis by hypoxia-inducible factor in non small cell lung cancer cell lines , 2006, Cancer biology & therapy.

[12]  Kevin Wei,et al.  A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development , 2006, The Journal of experimental medicine.

[13]  C. Bucana,et al.  Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  A. Baccarelli,et al.  The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study , 2006, Breast Cancer Research and Treatment.

[15]  S. Rafii,et al.  Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue , 2006, Current opinion in hematology.

[16]  P. Delrio,et al.  Overexpression of Both CXC Chemokine Receptor 4 and Vascular Endothelial Growth Factor Proteins Predicts Early Distant Relapse in Stage II-III Colorectal Cancer Patients , 2006, Clinical Cancer Research.

[17]  T. Kipps,et al.  CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. , 2006, Blood.

[18]  Lisa A Carey,et al.  Current Treatment Paradigms for the Management of Patients with Brain Metastases , 2005, Neurosurgery.

[19]  M. Thelen,et al.  The Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T Lymphocytes* , 2005, Journal of Biological Chemistry.

[20]  G. Watkins,et al.  The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer. , 2005, Breast.

[21]  J. Posner,et al.  Brain metastases: epidemiology and pathophysiology , 2005, Journal of Neuro-Oncology.

[22]  Y. Zeng,et al.  Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome , 2005, Journal of Translational Medicine.

[23]  Gerardo Botti,et al.  Expression of CXCR4 Predicts Poor Prognosis in Patients with Malignant Melanoma , 2005, Clinical Cancer Research.

[24]  S. Nie,et al.  Inhibition of Breast Cancer Metastasis by Selective Synthetic Polypeptide against CXCR4 , 2004, Cancer Research.

[25]  Tae-Hee Lee,et al.  Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells. , 2004, Molecular cancer research : MCR.

[26]  G. Broggi,et al.  CXCL12 in Malignant Glial Tumors: A Possible Role in Angiogenesis and Cross-Talk between Endothelial and Tumoral Cells , 2004, Journal of Neuro-Oncology.

[27]  F. André,et al.  Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[28]  M. Burdick,et al.  The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. , 2003, American journal of respiratory and critical care medicine.

[29]  R. Nibbs,et al.  The Chemokine ESkine/CCL27 Displays Novel Modes of Intracrine and Paracrine Function1 , 2002, The Journal of Immunology.

[30]  M. Mori,et al.  Regional Expression of CXCL12/CXCR4 in Liver and Hepatocellular Carcinoma and Cell‐cycle Variation during in vitro Differentiation , 2002, Japanese journal of cancer research : Gann.

[31]  Lei Yao,et al.  Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. , 2002, Blood.

[32]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[33]  R. Alon,et al.  The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. , 2000, Blood.

[34]  N. Tarasova,et al.  Spontaneous and Ligand-induced Trafficking of CXC-Chemokine Receptor 4* , 1998, The Journal of Biological Chemistry.

[35]  L Gaspar,et al.  Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. , 1997, International journal of radiation oncology, biology, physics.

[36]  S. Hassenbusch,et al.  Surgery versus radiosurgery in the treatment of brain metastasis. , 1996, Journal of neurosurgery.

[37]  P. Casanova,et al.  Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system. , 2003, Glia.

[38]  S. Dudas,et al.  Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.